Monoclonal gammopathy of undetermined significance (MGUS) was identified in 3.2% of 21
463 residents of Olmsted County, Minnesota, 50 years of age or older. The risk of …

Multiple myeloma (MM) is a fatal plasma cell dyscrasia with a median overall survival of 5 to
10 years. MM progresses from the more common but often subclinical precursor states of …

Multiple myeloma (MM) is the most common hematologic malignancy in blacks. Some prior
studies suggest inferior survival in blacks; others suggest similar survival. Using the original …

Monoclonal gammopathy of undetermined significance (MGUS) is, in many ways, a unique
hematologic entity. Unlike most hematologic conditions in which the diagnosis is intentional …

Monoclonal gammopathy of undetermined significance (MGUS) is one of the most common
premalignant disorders in Western countries. Recent studies show that almost every multiple …

Patients with multiple myeloma (MM) have an increased risk of venous thrombosis.
Interestingly, excess risk of venous thromboembolism has been observed among patients …

Background Prevalence estimates for monoclonal gammopathy of undetermined
significance (MGUS) are based on predominantly White study populations screened by …

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma
cell dyscrasia that consistently precedes multiple myeloma (MM) with a 1% risk of …

There are significant disparities with regards to incidence, timely diagnosis, access to
treatment, clinical trial participation and health care utilization that negatively impact …

Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of
plasma cells. The incidence of MM worldwide is increasing with greater than 140 000 …